drugset / Trial / NCT00927212

Topical Application of AS101 for the Treatment of Atopic Dermatitis

NCT00927212

Phase 2 Terminated 5 enrolled BioMAS Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Atopic Dermatitis is a chronic non contagious disease that causes itchy, inflamed skin. The purpose of this study is to evaluate the safety and efficacy of topical AS101 ointment for the treatment of Atopic dermatitis.

Timeline

Start
2009-06
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject TRICHLOROTELLURATE Small molecule 2 % Topical
Subject TRICHLOROTELLURATE Small molecule 4 % Topical

Indications